| About the author: |
O. M. Bilovol, I. I. Knyazkova, O. M. Kіrіenko, N. V. Kuzminova, D. O. Kirіenko, M. V. Bogun, A. O. Havryliuk |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
We examined 60 patients with stage II hypertension (HT), grade 2, mean age 54.7±3.8 years. The first group consisted of 30 patients with hypertension of the II stage, the second group included 30 patients with HT with comorbid moderate, subcompensated type 2 diabetes mellitus (DM). The control group consisted of 20 healthy individuals. All subjects underwent clinical and laboratory examination including the level of soluble growth-stimulating receptor expressed by gene 2 (sST2) in serum, echocardiography with an assessment of mitral Doppler blood flow. It was determined that the serum level of sST2 was significantly (p<0.05) higher in patients with comorbidity of HT and DM compared with HT without DM. Significant (p<0.05) positive correlations were found between sST2 level and regurgitation rate on tricuspid valve, E/e ', E/A ratio. The significant (p<0.05) negative relationships were found between sST2 and values of e's, e'l, e'avg. Therefore, an increased level of the sST2 biomarker is associated with the progression of left ventricular diastolic dysfunction in case of comorbidity of HT and type 2 DM. The results of the study suggest sST2 as one of the possible serum markers of diastolic left ventricular dysfunction in comorbid patients with HT and DM. |
| Tags |
comorbidity of hypertension and type 2 diabetes mellitus, diastolic dysfunction, soluble growth-stimulating receptor expressed by gene 2 |
| Bibliography |
- Kovalenko VM, Lutai MI, Sirenko YuM, Suchov OS. Serdtsevo-sudynni zakhvoruvannyia. Klasyfikatsiya, standarty diahnostyky ta likuvannya. Vseukr. asots. kardiolohiv; 4te vyd., pererobl. i dopov. Kyiv: Morion, 2020; 240. [in Ukrainian]
- Mankovskyi B. Insulinoterapia: doza maye znachennya. Diabet. Ozhyrinnia. Metabolichnyi syndrome. 2020; 2 (9): 27–32. [in Ukrainian]
- Treumova SI, Trybrat TA, Shut SV, Redchyts IV, Kazakov YuM. Ekhokardiohrafichni pokaznyky systolichnoyi ta diastolichnoyi funktsiyi livoho shlunochka u khvorykh pokhyloho viku na khronichne leheneve sertse bronkholehenevoho genezu u poyednanni z ishemichnoyu khvoroboyu sertsya. Visnyk problem biolohiyi i medytsyny. 2020; 1 (155): 208–211. [in Ukrainian]
- Barakat GM, Nuwayri-Salti N, Kadi LN, Bitar KM, Al-JaroudiWA, Bikhazi AB. Role of glucagon-like peptide-1 and its agonists on early prevention of cardiac remodeling in type 1 diabetic rat hearts. Gen Physiol Biophys. 2011; 30 (1): 34–44. DOI 10.4149/gpb_2011_01_34 Web of Science Id WOS:000288888600005
- Gilca GE, Stefanescu G, Badulescu O, Tanase DM, Bararu I, Ciocoiu M. Diabetic Cardiomyopathy: Current Approach and Potential Diagnostic and Therapeutic Targets. J Diabetes Res. 2017; 2017:1310265. DOI: 10.1155/2017/1310265
- Ian H. de Boer, Bangalore S, Benetos A, Davis AM, Michos ED, Muntner P. et al. Diabetes and Hypertension: A Position Statement by the American Diabetes Association. Diabetes Care. 2017; 40: 1273–84. DOI:10.2337/dci17-0026
- Joaquin C, Alonso N, Lupon J, Marta de Antonio, Domingo M, Moliner P, et al. Mini Nutritional Assessment Short Form is a morbi-mortality predictor in outpatients with heart failure and mid-range left ventricular ejection fraction. Clin Nutr. 2020; 39 (11): 3395–3401. DOI: 10.1016/j.clnu.2020.02.031
- Lee WS, Kim J. Diabetic cardiomyopathy: where we are and where we are going. Korean J Intern Med. 2017; 32 (3): 404–421. DOI: 10.3904/kjim.2016.208
- Prior DL, Somaratne JB, Jenkins AJ, Yii M., Newcomb AE, Schalkwijk CG, et al. Calibrated integrated backscatter and myocardial fibrosis in patients undergoing cardiac surgery. Open Heart. 2015; 2 (1): e000278. doi: 10.1136/openhrt-2015-000278. http://dx.doi.org/10.1136/openhrt-2015-000278
- Wallner M, Eaton DM, Berretta RM, Liesinger L, Schittmayer M, Gindlhuber J, et al. HDAC inhibition improves cardiopulmonary function in a feline model of diastolic dysfunction. Sci Transl Med. 2020; 12 (525): eaay7205. DOI 10.1126/scitranslmed.aay7205 Web of Science Id WOS:000507499600006
|
| Publication of the article |
«World of Medicine and Biology» №1(79), 2022 year, 025-028 pages, index UDK 616.12-008.318.4: 616.12-008.331.1 |
| DOI |
10.26724/2079-8334-2022-1-79-25-28 |
